Clinical Trials on Somatostatin Receptor-positive Neuroendocrine Tumor
Total 4468 results
-
Hutchison Medipharma LimitedCompletedNeuroendocrine TumorsChina
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Chang Gung Memorial Hospital; National Cheng-Kung...Completed
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsFinland, Norway, Sweden, Denmark, Latvia, Lithuania, Estonia
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
Nanjing Leads Biolabs Co.,LtdRecruitingAdvanced Neuroendocrine CarcinomaChina
-
Tianjin Medical University Cancer Institute and...RecruitingGastric Neuroendocrine CarcinomaChina
-
Hutchison Medipharma LimitedRecruitingAdvanced Neuroendocrine CarcinomaChina
-
M.D. Anderson Cancer CenterTerSera Therapeutics LLCRecruitingLocally Advanced Neuroendocrine Neoplasm | Metastatic Neuroendocrine NeoplasmUnited States
-
Barwon HealthAustralasian Gastro-Intestinal Trials Group; Deakin University; Specialised Therapeutics...UnknownGastrointestinal Neuroendocrine CarcinomasAustralia
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)WithdrawnMerkel Cell Carcinoma | Neuroendocrine Neoplasm | Metastatic Carcinoid Tumor | Functional Pancreatic Neuroendocrine Tumor | Malignant Somatostatinoma | Metastatic Adrenal Gland Pheochromocytoma | Multiple Endocrine Neoplasia Type 1 | Multiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia... and other conditions
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Not yet recruiting
-
Power Life Sciences Inc.Not yet recruitingMerkel Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterEMD SeronoRecruitingMerkel Cell CarcinomaUnited States
-
Kartos Therapeutics, Inc.RecruitingMerkel Cell CarcinomaUnited States, Netherlands, Korea, Republic of, France, Germany, Spain, Canada, Italy, Australia, Brazil
-
4SC AGCompletedMerkel Cell CarcinomaSpain, Netherlands, Belgium, Germany, France, Italy
-
EMD Serono Research & Development Institute, Inc.CompletedCarcinoma, Merkel CellUnited States, Spain, Australia, Italy, Germany, France, Japan
-
Trans Tasman Radiation Oncology GroupCompleted
-
University of California, San FranciscoMerck Sharp & Dohme LLCRecruitingNeuroendocrine Tumors | High Grade Neuroendocrine Carcinoma, Any Site | Well-Differentiated Neuroendocrine CarcinomaUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Alberta Health servicesRecruiting
-
AHS Cancer Control AlbertaCross Cancer InstituteActive, not recruiting
-
Advanced Accelerator ApplicationsActive, not recruitingNeuroendocrine TumorsUnited Kingdom, Portugal, Spain, France, United States
-
Jules Bordet InstituteCompletedGastroenteropancreatic Neuroendocrine TumorsBelgium
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedNeuroendocrine Tumors | Pancreatic Neuroendocrine TumorsCanada
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCCompletedNeuroendocrine Tumors | Metastatic Neuroendocrine TumorsUnited States
-
Peking Union Medical College HospitalRecruitingGastrointestinal Neuroendocrine CarcinomaChina
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Memorial Sloan Kettering Cancer CenterCuradev PharmaRecruiting
-
Gruppo Oncologico del Nord-OvestRecruitingMerkel Cell CarcinomaItaly
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLC; Novartis; GI Research FoundationRecruitingMerkel Cell CarcinomaUnited States
-
Abramson Cancer Center at Penn MedicineMerck Sharp & Dohme LLCRecruitingMerkel Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
University of BirminghamEfficacy and Mechanism Evaluation (EME) ProgrammeCompletedMerkel Cell CarcinomaUnited Kingdom
-
Merck Sharp & Dohme LLCCompletedMerkel Cell CarcinomaUnited States, Australia, Canada, France, Italy, New Zealand, Spain, Sweden
-
Immunomic Therapeutics, Inc.Completed
-
ImmunityBio, Inc.TerminatedMerkel Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedGastro-enteropancreatic Neuroendocrine Tumor | Secondary Malignant Neoplasm of LiverUnited States
-
4SC AGMerck KGaA, Darmstadt, GermanyWithdrawn
-
ImmunityBio, Inc.Withdrawn
-
Immune DesignCompletedMerkel Cell CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedNeuroendocrine Tumors | Carcinoma, Neuroendocrine | Neuroendocrine Carcinoma | Neuroendocrine Neoplasms | Neuroendocrine Tumors of the Gastrointestinal Tract and PancreasUnited States
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
National Cancer Institute (NCI)CompletedRecurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage IV Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the Skin | Stage I Neuroendocrine Carcinoma of the SkinUnited States
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
University of California, San FranciscoTerminatedALK Fusion Protein Expression | Stage III Cutaneous Melanoma | Stage IIIA Cutaneous Melanoma | Stage IIIB Cutaneous Melanoma | Stage IIIC Cutaneous Melanoma | Stage IV Cutaneous Melanoma | ROS1 Fusion Positive | BRAF wt Allele | Invasive Skin Melanoma | MET Fusion Gene Positive | NRAS wt Allele | NTRK1 Fusion... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Extrapulmonary Neuroendocrine Carcinoma | Metastatic Extrapulmonary Neuroendocrine Carcinoma | Recurrent Extrapulmonary Neuroendocrine Carcinoma | Unresectable Extrapulmonary Neuroendocrine CarcinomaUnited States
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbHRecruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Gencurix, Inc.RecruitingEarly Hormone Receptor-positive Breast CancerKorea, Republic of